Answers are grounded in this paper and cite their sources.
Assesses national prevalence of metastatic breast cancer in Australia, suggesting improved data for care planning.
High-quality metastatic breast cancer (MBC) data are needed to quantify burden, identify inequities, and plan treatment and supportive care. In Australia, many population-based registries capture incidence and mortality but do not routinely record stage or recurrence/progression, limiting national MBC prevalence measurement.
No takes yet. Share an insight, caveat, or question.
Durston et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: